Status:
COMPLETED
Reactions to Contrast Media (CM) Administered at the Time of the Endoscopic Retrograde Cholangiopancreatography (ERCP)
Lead Sponsor:
University of Florida
Conditions:
Contrast Allergies
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to prospectively document the incidence of CM adverse reactions at the time of ERCP and to determine whether various perceived risk factors are predictive of adverse reaction....
Eligibility Criteria
Inclusion
- Age 18 years or older.
- Scheduled to undergo ERCP at the University of Florida, Gainesville, FL
- History of prior reaction to IV CM and/or shellfish allergy
- Subject must be able to give informed consent
Exclusion
- Any contraindication to performing ERCP.
- Participation in another research protocol that could interfere or influence the outcomes measures of the present study.
- The subject is unable/unwilling to give informed consent.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00900640
Start Date
May 1 2009
End Date
March 1 2017
Last Update
March 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shands UF endoscopy Center
Gainesville, Florida, United States, 32610